News

Featured news from NHIVNA

HIV-related news from NAM

Pre-exposure prophylaxis also stops 86% of HIV infections in Ipergay study
Gus Cairns, 2015-02-24 20:30:00

A French and Canadian study of pre-exposure prophylaxis (PrEP) presented today at the Conference on Retroviruses and Opportunistic Infections (CROI 2015) in Seattle, USA, found that the HIV infection rate in participants taking an intermittent PrEP regime was 86% lower than in people taking an inactive placebo.

Extraordinarily, this is exactly the same level of effectiveness that was demonstrated in the English PROUD study, the outcomes of which were presented 15 minutes before Ipergay – see this report.

Ipergay is a very different study from PROUD, and it is encouraging that two different ways of taking PrEP have both proved effective in gay men, at least in a western-European context.

Source:1